Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis

[1]  D. Musch,et al.  Cataract in the Adult Eye Preferred Practice Pattern®. , 2017, Ophthalmology.

[2]  M. Jabbarvand,et al.  Endophthalmitis Occurring after Cataract Surgery: Outcomes of More Than 480 000 Cataract Surgeries, Epidemiologic Features, and Risk Factors. , 2016, Ophthalmology.

[3]  D. Chang,et al.  Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital. , 2016, Ophthalmology.

[4]  L. Sobrin,et al.  Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin. , 2015, Ophthalmology.

[5]  D. Chang,et al.  Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2014 ASCRS member survey , 2015, Journal of cataract and refractive surgery.

[6]  J. Hjortdal,et al.  Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta‐analysis , 2015, Acta ophthalmologica.

[7]  Savitri Sharma,et al.  Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India , 2015, Journal of cataract and refractive surgery.

[8]  D. Chang,et al.  Intracameral antibiotics: Safety, efficacy, and preparation. , 2014, Journal of cataract and refractive surgery.

[9]  P. Barry.  Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: Update on the ESCRS Endophthalmitis Study , 2014, Journal of cataract and refractive surgery.

[10]  C. Suto,et al.  Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan , 2013, Journal of cataract and refractive surgery.

[11]  F. E. Sayyad,et al.  Moxifloxacin and bilateral acute iris transillumination , 2013, Journal of Ophthalmic Inflammation and Infection.

[12]  U. Stenevi,et al.  Six‐year incidence of endophthalmitis after cataract surgery: Swedish national study , 2013, Journal of cataract and refractive surgery.

[13]  L. Herrinton,et al.  Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department , 2013, Journal of cataract and refractive surgery.

[14]  Emily W. Gower,et al.  Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. , 2013, Cochrane Database of Systematic Reviews.

[15]  C. Cook,et al.  Endophthalmitis prophylaxis with intracameral cefuroxime in South Africa. , 2012, Journal of cataract and refractive surgery.

[16]  P. Robert,et al.  Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study , 2012, Journal of cataract and refractive surgery.

[17]  Pärssinen Olavi.  Ocular toxicity in cataract surgery because of inaccurate preparation and erroneous use of 50mg/ml intracameral cefuroxime , 2012, Acta ophthalmologica.

[18]  C. Suto,et al.  Bag and chamber flushing: a new method of using intracameral moxifloxacin to irrigate the anterior chamber and the area behind the intraocular lens , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[19]  S. Arshinoff,et al.  Incidence of postoperative endophthalmitis after immediate sequential bilateral cataract surgery , 2011, Journal of cataract and refractive surgery.

[20]  D. Chang,et al.  Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis , 2011, Journal of cataract and refractive surgery.

[21]  R. O'Callaghan,et al.  Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin‐sensitive or methicillin‐resistant Staphylococcus aureus anterior chamber infections , 2010, Journal of cataract and refractive surgery.

[22]  R. Lee,et al.  Aqueous Humor Dynamics: A Review , 2010, The open ophthalmology journal.

[23]  G. Rodríguez-Caravaca,et al.  Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery: Ten‐year comparative study , 2010, Journal of cataract and refractive surgery.

[24]  C. L. Moser,et al.  Prophylactic intracameral cefazolin after cataract surgery: Endophthalmitis risk reduction and safety results in a 6‐year study , 2009, Journal of cataract and refractive surgery.

[25]  Erik A Hermans,et al.  Constant volume of the human lens and decrease in surface area of the capsular bag during accommodation: an MRI and Scheimpflug study. , 2009, Investigative ophthalmology & visual science.

[26]  S. Masket,et al.  Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery , 2008, Journal of cataract and refractive surgery.

[27]  Arbisser Lb.  Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. , 2008 .

[28]  L. Arbisser.  Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery , 2008, Journal of cataract and refractive surgery.

[29]  T. O'brien,et al.  Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: Potential role of moxifloxacin , 2007, Journal of cataract and refractive surgery.

[30]  S. Masket,et al.  Prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2007 ASCRS member survey , 2007, Journal of cataract and refractive surgery.

[31]  G. Gettinby,et al.  Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors , 2007, Journal of cataract and refractive surgery.

[32]  U. Stenevi,et al.  Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. , 2007, Ophthalmology.

[33]  L. Ong-Tone.  Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery , 2007, Journal of cataract and refractive surgery.

[34]  V. Caparas,et al.  Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients , 2007, Journal of cataract and refractive surgery.

[35]  A. Venkatraman,et al.  The effect of moxifloxacin on the normal human cornea , 2006, Current medical research and opinion.

[36]  S. Wu,et al.  Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models. , 2006, Investigative ophthalmology & visual science.

[37]  H. Flynn,et al.  In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. , 2006, Archives of ophthalmology.

[38]  G. Gettinby,et al.  ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study , 2006, Journal of cataract and refractive surgery.

[39]  G. Gettinby,et al.  ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study , 2006, Journal of cataract and refractive surgery.

[40]  Juan Fernández,et al.  Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery , 2006, Journal of cataract and refractive surgery.

[41]  J. Dick,et al.  Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. , 2005, Ophthalmology.

[42]  E. Romanowski,et al.  Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. , 2005, American journal of ophthalmology.

[43]  M. Abelson,et al.  Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. , 2005, Archives of ophthalmology.

[44]  L. Fry.  Vancomycin dilution error. , 2005, Journal of cataract and refractive surgery.

[45]  K. Bower,et al.  The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy. , 2005, American journal of ophthalmology.

[46]  U. Stenevi,et al.  Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001. , 2005, Acta ophthalmologica Scandinavica.

[47]  F. Mah.  Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections , 2004, Current opinion in ophthalmology.

[48]  E. Romanowski,et al.  Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. , 2004, American journal of ophthalmology.

[49]  L. Sabath,et al.  Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  D. Hwang.  Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. , 2004, Survey of ophthalmology.

[51]  Ophthalmic moxifloxacin (Vigamox) and gatifloxacin (Zymar). , 2004, The Medical letter on drugs and therapeutics.

[52]  E. Romanowski,et al.  Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. , 2003, American journal of ophthalmology.

[53]  J. Caeiro,et al.  Moxifloxacin (Avelox®): a novel fluoroquinolone with a broad spectrum of activity , 2003, Expert review of anti-infective therapy.

[54]  G. Koranyi,et al.  Prophylactic intracameral cefuroxime: Efficacy in preventing endophthalmitis after cataract surgery , 2002, Journal of cataract and refractive surgery.

[55]  C. Zetterström,et al.  Prophylactic intracameral cefuroxime: Evaluation of safety and kinetics in cataract surgery , 2002, Journal of cataract and refractive surgery.

[56]  E. Romanowski,et al.  Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. , 2002, American journal of ophthalmology.

[57]  Y. Gordon,et al.  Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes? , 2001, American journal of ophthalmology.

[58]  A. Bauernfeind.  Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. , 1997, The Journal of antimicrobial chemotherapy.

[59]  H. Gimbel,et al.  Prophylactic Intracameral Antibiotics During Cataract Surgery: The Incidence of Endophthalmitis and Corneal Endothelial Cell Loss , 1994 .

[60]  J. Gills.  Filters and Antibiotics in Irrigating Solution for Cataract Surgery , 1991, Journal of cataract and refractive surgery.

[61]  C. Stratton,et al.  Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies , 1987, Antimicrobial Agents and Chemotherapy.